TP53 and acute myeloid leukemia: Previous studies have demonstrated that combination of BCL-2 inhibitors with MCL-1 inhibitors,29 JAK1/2 inhibitors,30 and TKIs31 or P53 activators24 can synergistically eliminate AML cells.